Protocol Design Trends Investigators Should Look for When Selecting Studies
For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote…
Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Start with the Patient in Mind – Interview With Patient Partner Donnie King
Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance…
Overcoming Barriers to Enrolling Renal Patients in Clinical Trials: Q&A With Kurt Mussina
Kurt Mussina, General Manager of Frenova Renal Research and Vice President of Clinical Studies Operations for Fresenius Medical Care North…
Research as Care
Speed is key in bringing new drugs to patients. Speed in clearing regulatory hurdles, gearing up to product launch, gaining…
Changing Ways: Patient Participation
For many patients across a wide range of therapeutic areas, participation in a clinical trial can provide access to important…
Prevent the Real World From Derailing Your Clinical Trial: Focus On Protocol Design
Clinical trial sponsors are continually seeking ways to improve the speed and efficiency of their clinical development projects. However, they…
Vifor Case Study: A Pivotol Phase III Study for FDA Approval of Velphoro® (Sucroferric Oxyhydroxide), a Hyperphosphatemia Medication
Enrolling patients affected by chronic kidney disease can be particularly challenging. With multiple comorbidities, they are often reluctant to undergo…